April 2022

Manufacturers continue denying 340B pricing to safety-net hospitals

340B Pricing for Drugs Dispensed in Community Pharmacies

Manufacturers continue denying 340B pricing to safety-net hospitals Issue Overview Beginning in July 2020, several major drug companies have stopped providing, or have imposed restrictions on, 340B pricing to covered entities for their drugs that are dispensed through community pharmacies. These policies are in violation of manufacturers’ obligations under the 340B statute to offer discounted

340B Pricing for Drugs Dispensed in Community Pharmacies Read More »

Scroll to Top